Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Monocyte/HDL Cholesterol Ratios as a New Inflammatory Marker in Patients with Schizophrenia

Open access
Kılıç, Nülüfer, Tasci, Gulay, Yılmaz, Seda, Öner, Pınar, Korkmaz, Sevda · 2023 · Journal of Personalized Medicine

Abstract

Purpose: Monocyte/HDL cholesterol ratio (MHR) is a novel inflammatory marker that is used as a prognostic factor for cardiovascular diseases and has been studied in many diseases. The aim of this study was to investigate the role of inflammatory factors in schizophrenia patients by examining MHR levels and to compare schizophrenia patients and healthy controls in terms of cardiovascular disease risk. Method: A total of 135 participants between the ages of 18–65, 85 diagnosed with schizophrenia, and 50 healthy individuals in the control group were included in this cross-sectional study. Venous blood samples were taken from the participants and CBC parameters and lipid profiles were analyzed. The sociodemographic and clinical data form and positive and negative symptoms scale (PANSS) were administered to all participants. Results: Although monocyte levels were significantly higher in the patient group, HDL-C levels were lower at significant levels. MHR was found to be higher in the patient group compared to the control group at significant levels. When compared to the control group, total cholesterol, triglyceride, WBC, neutrophil, basophil, and platelet levels were higher in the patient group at significant levels, and RBC, hemoglobin, and hematocrit levels were significantly lower. Conclusion: The elevated MHR in patients with schizophrenia may contribute to our understanding that inflammation plays important roles in the pathophysiology of schizophrenia. Additionally, knowing the levels of MHR and considering the recommendations, such as diet and exercise, in the treatment approaches made us think that it might be beneficial in protecting schizophrenia patients against cardiovascular diseases and early death.

Overview

Integrity signals

Registry

Crossref · 10.3390/jpm13020276

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Figures

Figure 1 ROC curve.
Figure 1 ROC curve.CC BY · PubMed Central

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 44 references

Research works printed but not linked: 2

  1. 2021, Comparison of Sleep Quality and Monocyte/High Density Lipoprotein Ratio by Physical Activity Level in Healthy Women, Kırıkkale Üniversitesi Tıp Fakültesi Derg., 23, 522
  2. First, 1987, Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P) New York: Biometrics Research, New York State Psychiatric Institute; 2002, Schizophr Bull., 13, 261

Cited by

See all 15

Metadata

Authors
Kılıç, N., Tasci, G., Yılmaz, S., Öner, P., & Korkmaz, S.
Affiliations
  • Elazığ Fethi Sekin City Hospital, Department of Psychiatry, Elazığ 23100, Türkiye
  • Elazığ Fethi Sekin City Hospital, Department of Microbiology, Elazığ 23100, Türkiye
  • Fırat University (TR)
Venue
Journal of Personalized Medicine
Publisher
MDPI AG
Published
2023-01-31
Volume
13
Issue
2
Pages
276
ISSN
2075-4426 (ISSN-L)
OpenAlex
W4318829874
Cited by
15
References
44
Citations by year
2026: 1 · 2025: 7 · 2024: 3 · 2023: 4
FWCI
3.04
Type
journal article
Language
en
Open access
Locations
  • Journal of Personalized Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DSpace - FIRAT (Fırat University) (submittedVersion, cc-by-nc-nd)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
Keywords
schizophrenia, inflammation, inflammatory markers, cardiovascular risk, HDL cholesterol, monocytes, lipid profile, white blood cell count, schizophrenia pathophysiology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Monocyte/HDL Cholesterol Ratios as a New Inflammatory Marker in Patients with Schizophrenia. https://app.cochat.ai/papers/10.3390/jpm13020276
The paper
Kılıç, N., Tasci, G., Yılmaz, S., Öner, P., & Korkmaz, S. (2023). Monocyte/HDL Cholesterol Ratios as a New Inflammatory Marker in Patients with Schizophrenia. Journal of Personalized Medicine. https://doi.org/10.3390/jpm13020276

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.